Related Experiment Video
Updated: Sep 12, 2025
08:47
Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.6K
Harnessing Fc-Directed Bioconjugation for the Synthesis of Site-Specifically Modified Radioimmunoconjugates
Camilla Grimaldi1,2,3, Joni Sebastiano1,2,3, Wei-Siang Mark Kao1,3
1Department of Chemistry, Hunter College, The City University of New York, New York, New York 10065-5024, United States.
Bioconjugate Chemistry
|August 9, 2025
Summary
A new, simple method for site-specific radioimmunoconjugate synthesis improves in vivo performance for cancer therapy. This approach offers enhanced stability and tumor targeting compared to traditional methods.
Area of Science:
- Bioconjugation Chemistry
- Radiopharmaceutical Development
- Cancer Therapeutics
Background:
- Site-specific immunoconjugate modification enhances in vivo performance but faces challenges in clinical translation due to complexity and cost.
- Existing methods for site-specific bioconjugation often involve instability, intricate procedures, and high expenses, hindering their widespread clinical application.
Purpose of the Study:
- To develop a novel, simple, and straightforward chemical approach for synthesizing site-specifically modified radioimmunoconjugates.
- To create a stable and immunoreactive radioimmunoconjugate for potential pancreatic cancer therapy.
Main Methods:
- An Fc-directed peptide was used to introduce unique free sulfhydryl moieties onto the Fc domain of the CA19-9 antibody (5B1).
- These thiols were conjugated with phenyloxadiazolyl methylsulfone variants of CHX-A″-DTPA, followed by radiolabeling with Lutetium-177 ([177Lu]Lu3+).
- The resulting radioimmunoconjugate, [177Lu]Lu-DTPA-PODSAJICAP-5B1, was characterized for yield, purity, specific activity, site-specificity, stability, and immunoreactivity.
Main Results:
- [177Lu]Lu-DTPA-PODSAJICAP-5B1 was synthesized in high yield, purity, and specific activity, confirming site-specific modification.
- The radioimmunoconjugate demonstrated high stability and retained immunoreactivity.
- Biodistribution studies in pancreatic cancer xenografts showed high tumor activity concentrations and tumor-to-background ratios, outperforming traditional methods.
Conclusions:
- The novel Fc-directed peptide approach provides a simple and effective method for site-specific radioimmunoconjugate synthesis.
- This method yields a stable, immunoreactive, and high-performing radioimmunoconjugate with potential for improved pancreatic cancer treatment.
- The developed technique offers a promising alternative to existing bioconjugation strategies for clinical translation.
